These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 8421205)

  • 1. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study.
    Coffey JR; Cahill D; Steers W; Park TS; Ordia J; Meythaler J; Herman R; Shetter AG; Levy R; Gill B
    J Neurosurg; 1993 Feb; 78(2):226-32. PubMed ID: 8421205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal baclofen for treatment of intractable spinal spasticity.
    Abel NA; Smith RA
    Arch Phys Med Rehabil; 1994 Jan; 75(1):54-8. PubMed ID: 8291963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries.
    Korenkov AI; Niendorf WR; Darwish N; Glaeser E; Gaab MR
    Neurosurg Rev; 2002 Aug; 25(4):228-30. PubMed ID: 12172730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal baclofen for severe spinal spasticity.
    Penn RD; Savoy SM; Corcos D; Latash M; Gottlieb G; Parke B; Kroin JS
    N Engl J Med; 1989 Jun; 320(23):1517-21. PubMed ID: 2657424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
    Draulans N; Vermeersch K; Degraeuwe B; Meurrens T; Peers K; Nuttin B; Kiekens C
    Clin Rehabil; 2013 Dec; 27(12):1137-43. PubMed ID: 23858524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury.
    Loubser PG; Narayan RK; Sandin KJ; Donovan WH; Russell KD
    Paraplegia; 1991 Jan; 29(1):48-64. PubMed ID: 2023770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
    Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic intrathecal baclofen administration for control of severe spasticity.
    Lazorthes Y; Sallerin-Caute B; Verdie JC; Bastide R; Carillo JP
    J Neurosurg; 1990 Mar; 72(3):393-402. PubMed ID: 2303874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dosage and administration of long-term intrathecal baclofen therapy for severe spasticity of spinal origin.
    Kawano O; Masuda M; Takao T; Sakai H; Morishita Y; Hayashi T; Ueta T; Maeda T
    Spinal Cord; 2018 Oct; 56(10):996-999. PubMed ID: 29895878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up.
    Azouvi P; Mane M; Thiebaut JB; Denys P; Remy-Neris O; Bussel B
    Arch Phys Med Rehabil; 1996 Jan; 77(1):35-9. PubMed ID: 8554471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional outcome of intrathecal baclofen administration for severe spasticity.
    Boviatsis EJ; Kouyialis AT; Korfias S; Sakas DE
    Clin Neurol Neurosurg; 2005 Jun; 107(4):289-95. PubMed ID: 15885386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intrathecal baclofen for severe spasticity].
    Ueta T
    Brain Nerve; 2008 Dec; 60(12):1415-20. PubMed ID: 19110752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous intrathecal baclofen in spinal cord spasticity. A prospective study.
    Meythaler JM; Steers WD; Tuel SM; Cross LL; Haworth CS
    Am J Phys Med Rehabil; 1992 Dec; 71(6):321-7. PubMed ID: 1466869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin.
    Zahavi A; Geertzen JH; Middel B; Staal M; Rietman JS
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1553-7. PubMed ID: 15489386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal baclofen infusion: an innovative approach for controlling spinal spasticity.
    Savoy SM; Gianino JM
    Rehabil Nurs; 1993; 18(2):105-13. PubMed ID: 8451504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity.
    Ordia JI; Fischer E; Adamski E; Spatz EL
    J Neurosurg; 1996 Sep; 85(3):452-7. PubMed ID: 8751632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal baclofen for severe spasticity secondary to spinal cord injury.
    Lewis KS; Mueller WM
    Ann Pharmacother; 1993 Jun; 27(6):767-74. PubMed ID: 8329801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal baclofen: does tolerance occur?
    Akman MN; Loubser PG; Donovan WH; O'Neill ME; Rossi CD
    Paraplegia; 1993 Aug; 31(8):516-20. PubMed ID: 8414636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional outcome after delivery of intrathecal baclofen.
    Parke B; Penn RD; Savoy SM; Corcos D
    Arch Phys Med Rehabil; 1989 Jan; 70(1):30-2. PubMed ID: 2916915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological complications of the chronic baclofen infusion in the severe spinal spasticity. Personal experience and review of the literature.
    Dario A; Scamoni C; Picano M; Casagrande F; Tomei G
    J Neurosurg Sci; 2004 Dec; 48(4):177-81. PubMed ID: 15876986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.